Estimates Revisions Abbott Laboratories Kazakhstan S.E.
Stocks
ABT_KZ
US0028241000
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Cboe BZX
11:55:36 07/10/26 pm AEDT
|
5-day change | 1st Jan Change | ||
| 97.16 USD | -11.67% |
|
+4.76% | -23.61% |
| 11:14pm | Barclays Initiates Coverage on Abbott Laboratories With Overweight Rating, $120 Price Target | MT |
| 06/10 | Abbott Laboratories Receives FDA Approval for New CardioMEMS HF System capabilities | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Abbott Laboratories(ABT)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
Abbott Laboratories(ABT)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
Abbott Laboratories(ABT)
EBIT
Dividend / Share (DPS)
Data source:
Abbott Laboratories(ABT)
Cash or Net Debt
- Stock Market
- Stocks
- ABT Stock
- ABT_KZ Stock
- Consensus Abbott Laboratories
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
